hims & hers fda warning letter compounded semaglutide 2025 The sent a to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know Last month, the FDA issued

Over time, this can lead to loss of lean mass, reduced metabolic rate, and suboptimal body composition outcomes

When combined with education on balanced nutrition, basic meal planning, and ways to spot setbacks, users can stay on track

Residents across Louisiana see compounded semaglutide as a breakthrough for weight management

Unlike insulin , which can sometimes lead to weight gain by increasing the storage of glucose as fat, Ozempic works by mimicking the hormone GLP-1, which helps regulate appetite, promote a feeling of fullness after meals, and slow gastric emptying

For detailed management strategies, see our side effects guide